共 50 条
- [21] HOPE: Harnessing olaparib, palbociclib, and endocrine therapy for BRCA1/2-associated HR+, HER2-metastatic breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Shah, Payal DeepakTorres, AlexandraAaron, MeganNarayan, VivekKnollman, Hayley MichelleBradbury, Angela R.DeMichele, AngelaRobson, Mark E.Tung, Nadine M.Domchek, Susan M.
- [22] Neoadjuvant talazoparib in patients with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Results of a phase 2 study.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Litton, Jennifer KeatingBeck, Joseph ThaddeusJones, Jason M.Andersen, JayBlum, Joanne LorraineMina, Lida A.Brig, RaymondDanso, Michael A.Yuan, YuanAbbattista, AntonelloNoonan, KayChakrabarti, JayetaCzibere, AkosSymmans, William FraserTelli, Melinda L.
- [23] Talazoparib beyond BRCA: A phase II trial of talazoparib monotherapy in BRCA1 and BRCA2 wild-type patients with advanced HER2-negative breast cancer or other solid tumors with a mutation in homologous recombination (HR) pathway genes.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Gruber, Joshua JamesAfghahi, AnoshehHatton, AlyssaScott, DanikaMcMillan, AlexFord, James M.Telli, Melinda L.
- [24] Phase IV multicenter study evaluating RWE and the safety of talazoparib in patients with locally advanced or metastatic negative HER2 breast cancer and a BRCA1/2 mutation (ViTAL) - Cohort 2: patients treated according to the EMACANCER RESEARCH, 2023, 83 (05)Loirat, Delphinede la Barre, Marie DuboysVillanueva, CristianMailliez, AudreyIsambert, NicolasMoreau, LionelJacquet, EmmanuelleSpaeth, DominiqueCreisson, AnneJouannaud, ChristelleLegouffe, EricDelbado, MiguelDeiana, LauraSoibinet, PaulineHrab, IoanaGrellety, ThomasDohollou, NadineLongo, RaffaeleThery, Jean-ChristopheFumet, Jean-davidZineb, SellamPujol, Pascalde la Motte Rouge, thibault
- [25] Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World SettingBIOMEDICINES, 2022, 10 (12)McFarland, Taylor RyanThomas, Vinay MathewNussenzveig, RobertoGebrael, GeorgesSayegh, NicolasTripathi, NishitaSahu, Kamal KantGoel, DivyamMaughan, Benjamin L.Sirohi, DeepikaAgarwal, NeerajSwami, Umang
- [26] Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor MicroenvironmentCANCERS, 2023, 15 (09)Inoue, TakahiroSekito, ShoKageyama, TakumiSugino, YusukeSasaki, Takeshi
- [27] Real-world tumor BRCA testing patterns and PARP inhibitor use in HER2-negative metastatic breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Yadav, SiddharthaCouch, FergusLi, QixinHillman, SamLuo, LinlinHayes, JenniferMishkin, Kathryn EmilyXu, Xiaoqing
- [28] Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian CancerCLINICAL CANCER RESEARCH, 2017, 23 (21) : 6708 - 6720Weigelt, BrittaComino-Mendez, Inakide Bruijn, InoTian, LeiMeisel, Jane L.Garcia-Murillas, IsaacFribbens, CharlotteCutts, RosMartelotto, Luciano G.Ng, Charlotte K. Y.Lim, Raymond S.Selenica, PierPiscuoglio, SalvatoreAghajanian, CarolNorton, LarryMurali, RajmohanHyman, David M.Borsu, LaetitiaArcila, Maria E.Konner, JasonReis-Filho, Jorge S.Greenberg, Roger A.Robson, Mark E.Turner, Nicholas C.
- [29] Exploration of impact of tumor BRCA zygosity and genomic loss-of-heterozygosity (gLOH) on efficacy in Phase 3 EMBRACA study of talazoparib in patients (pts) with HER2-negative (HER2-) advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA1/2) mutationCANCER RESEARCH, 2020, 80 (16)Litton, Jennifer K.Laird, A. DouglasRugo, Hope S.Ettl, JohannesHurvitz, Sara A.Martin, MiguelRoche, HenriIm, Young-HyuckGoodwin, AnnabelBlum, Joanne L.Eiermann, WolfgangChen, YingLanzalone, SilvanaChelliserry, JijumonCzibere, AkosAlbacker, Lee A.Frampton, Garrett M.Mina, Lida A.
- [30] A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genesNATURE CANCER, 2022, 3 (10) : 1181 - +Gruber, Joshua J.Afghahi, AnoshehTimms, KirstenDeWees, AlyssaGross, WyattAushev, Vasily N.Wu, Hsin-TaBalcioglu, MustafaSethi, HimanshuScott, DanikaForan, JessicaMcMillan, AlexFord, James M.Telli, Melinda L.